anonymous
Guest
anonymous
Guest
Any way Supernus frames it this is far from what they led us to believe. For years they spoke of Qelbree as the second coming.
This product is terrible. If it does work it isn’t tolerated. If a patient doesn’t experience severe sedation they are experiencing hypomania. Not too mention we have no dosage response in our data.
Gary, we are selling a bag of shit and you just made it worse with this bonus plan. The product hasn’t even been out for a year and you are already cutting bonus! Come on man.
This product is terrible. If it does work it isn’t tolerated. If a patient doesn’t experience severe sedation they are experiencing hypomania. Not too mention we have no dosage response in our data.
Gary, we are selling a bag of shit and you just made it worse with this bonus plan. The product hasn’t even been out for a year and you are already cutting bonus! Come on man.